Wasatch Advisors Inc Castle Biosciences Inc Transaction History
Wasatch Advisors Inc
- $19.9 Billion
- Q4 2024
A detailed history of Wasatch Advisors Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 1,796,088 shares of CSTL stock, worth $46.2 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,796,088
Previous 1,826,092
1.64%
Holding current value
$46.2 Million
Previous $52.1 Million
8.09%
% of portfolio
0.24%
Previous 0.26%
Shares
22 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$78.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$47.2 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$37 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$25.7 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il835KShares$21.5 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $677M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...